+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Summit Therapeutics plc - logo

Summit Therapeutics is a biopharmaceutical company focussed on the development of novel medicines to treat the fatal muscle wasting disease Duchenne muscular dystrophy and infections caused by the bacteria C. difficile. The company is developing Ezutromid, an utrophin modulator product candidate that is in Phase II clinical trials used for to treat Duchenne muscular dystrophy disease. Summit Therapeutics plc was founded in 2003 and is based in Abingdon, the United Kingdom.

Carbapenem-Resistant Enterobacteriaceae - Pipeline Insight, 2022 - Product Thumbnail Image

Carbapenem-Resistant Enterobacteriaceae - Pipeline Insight, 2022

  • Drug Pipelines
  • July 2022
  • 70 Pages
  • Global
From
Bispecific Antibodies Market (5th Edition): Distribution by Therapeutic Area, Mechanism of Action, Target Antigen, Antibody Format, Key Players and Key Geographical Regions (North America, Europe, Asia and Rest of the World): Industry Trends and Global Forecasts, 2023-2035 - Product Thumbnail Image

Bispecific Antibodies Market (5th Edition): Distribution by Therapeutic Area, Mechanism of Action, Target Antigen, Antibody Format, Key Players and Key Geographical Regions (North America, Europe, Asia and Rest of the World): Industry Trends and Global Forecasts, 2023-2035

  • Report
  • May 2023
  • 391 Pages
  • Global
From
2019 Duchenne Muscular Dystrophy Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 - Product Thumbnail Image

2019 Duchenne Muscular Dystrophy Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • Report
  • April 2019
  • 165 Pages
  • Global
From
Acinetobacter Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Acinetobacter Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • July 2022
  • 173 Pages
  • Global
From
Clostridioides Difficile Infections (Clostridium Difficile Associated Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Clostridioides Difficile Infections (Clostridium Difficile Associated Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • July 2022
  • 259 Pages
  • Global
From
Klebsiella Pneumoniae Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Klebsiella Pneumoniae Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • July 2022
  • 138 Pages
  • Global
From
Clostridium Difficile Treatment - Global Strategic Business Report - Product Thumbnail Image

Clostridium Difficile Treatment - Global Strategic Business Report

  • Report
  • December 2023
  • 192 Pages
  • Global
From
2021 Clinical Trial Analytics of the Microbiome Landscape - Product Thumbnail Image

2021 Clinical Trial Analytics of the Microbiome Landscape

  • Report
  • April 2021
  • 9 Pages
  • Global
Global Clostridium Difficile Treatment Market 2021-2025 - Product Thumbnail Image

Global Clostridium Difficile Treatment Market 2021-2025

  • Report
  • July 2021
  • 120 Pages
  • Global
From
Global Bispecific Antibodies Market Size, Share & Industry Trends Analysis Report By Indication (Cancer, Inflammatory & Autoimmune Disorder and Others), By Regional Outlook and Forecast, 2023 - 2030 - Product Thumbnail Image

Global Bispecific Antibodies Market Size, Share & Industry Trends Analysis Report By Indication (Cancer, Inflammatory & Autoimmune Disorder and Others), By Regional Outlook and Forecast, 2023 - 2030

  • Report
  • June 2023
  • 126 Pages
  • Global
From
Clostridium Difficile Treatment Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Clostridium Difficile Treatment Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • October 2023
  • 100 Pages
  • Global
From
Antibody Discovery Market: Focus on Services and Platforms - Distribution by Type of Service Offered, Antibody Discovery Method, Type of Antibody Generated, Nature of Antibody Generated, Therapeutic Areas and Key Geographies: Industry Trends and Global Forecasts, 2023-2035 - Product Thumbnail Image

Antibody Discovery Market: Focus on Services and Platforms - Distribution by Type of Service Offered, Antibody Discovery Method, Type of Antibody Generated, Nature of Antibody Generated, Therapeutic Areas and Key Geographies: Industry Trends and Global Forecasts, 2023-2035

  • Report
  • October 2023
  • 552 Pages
  • Global
From
Global Antibiotics Market - Distribution by Type of Drug Class, Target Disease Indication, Type of Therapy (Monotherapies and Combination Therapies), Route of Administration and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035 - Product Thumbnail Image

Global Antibiotics Market - Distribution by Type of Drug Class, Target Disease Indication, Type of Therapy (Monotherapies and Combination Therapies), Route of Administration and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035

  • Report
  • April 2023
  • 175 Pages
  • Global
From
Duchenne Muscular Dystrophy - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Duchenne Muscular Dystrophy - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • November 2021
  • 223 Pages
  • Global
From
Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2016-2023 - Product Thumbnail Image

Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2016-2023

  • Report
  • September 2023
  • 700 Pages
  • Global
From
Klebsiella pneumoniae Infections - Pipeline Review, H2 2020 - Product Thumbnail Image

Klebsiella pneumoniae Infections - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 140 Pages
  • Global
From
Acinetobacter Infections - Pipeline Review, H2 2020 - Product Thumbnail Image

Acinetobacter Infections - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 204 Pages
  • Global
From
Clostridioides difficile Associated Enteropathy (Clostridium difficile Associated Enteropathy) - Pipeline Review, H2 2020 - Product Thumbnail Image

Clostridioides difficile Associated Enteropathy (Clostridium difficile Associated Enteropathy) - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 278 Pages
  • Global
From
Klebsiella pneumoniae Infections R&D Pipeline Analysis Report, Q4 2020 - Product Thumbnail Image

Klebsiella pneumoniae Infections R&D Pipeline Analysis Report, Q4 2020

  • Report
  • October 2020
  • 143 Pages
  • Global
From
Clostridioides difficile Infections (Clostridium difficile Associated Disease) - Pipeline Review, H1 2020 - Product Thumbnail Image

Clostridioides difficile Infections (Clostridium difficile Associated Disease) - Pipeline Review, H1 2020

  • Drug Pipelines
  • April 2020
  • 267 Pages
  • Global
From
Loading Indicator